New Research: Potential Cure for Recurrent UTIs
- Researchers at the University of Colorado Anschutz Medical Campus are exploring a novel approach to combatting urinary tract infections (UTIs).
- The innovative method involves creating nanogels combined with a special peptide.
- The findings, documented in Nanomedicine, reveal that this strategy demonstrated significant effectiveness in animal models with UTIs.The nanogel treatment eliminated over 90% of the bacteria from the bladder.
Nanogel Drug Delivery System Shows Promise for Treating Recurrent urinary Tract Infections
Table of Contents
- Nanogel Drug Delivery System Shows Promise for Treating Recurrent urinary Tract Infections
- Nanogel Drug Delivery for UTIs: Q&A on this Promising New Treatment
- What are Nanogels and How Do They Work in Treating UTIs?
- How Effective is nanogel Delivery for UTIs?
- What are the Key Benefits of Using nanogel Technology Compared to Traditional Antibiotics?
- How Does Nanogel Delivery Reduce the Risk of Antibiotic Resistance?
- What is Gentamicin?
- Could this Nanogel Technology be Used for Other Infections?
- Who is Involved in This Nanogel Research?
- Who Funded the Nanogel research?
- Nanogel Delivery vs. Traditional antibiotics: A Comparison
Published: 2025-03-12
Researchers at the University of Colorado Anschutz Medical Campus are exploring a novel approach to combatting urinary tract infections (UTIs). Their focus is on delivering antibiotics, specifically gentamicin, directly into the bladder tissue using a nanogel-based system.
Targeting UTIs with Nanogel Technology
The innovative method involves creating nanogels combined with a special peptide. This peptide facilitates the entry of the drug into the cells where bacteria frequently enough hide, making the treatment more effective.
Efficacy in Animal models
The findings, documented in Nanomedicine, reveal that this strategy demonstrated significant effectiveness in animal models with UTIs.The nanogel treatment eliminated over 90% of the bacteria from the bladder.
We prove not only that this technology is doable but could be vrey effective for future clinical use adn can perhaps lead towards an eventual cure of recurrent infections.
Michael Schurr, PhD, associate professor in the Department of Immunology & Microbiology at the University of Colorado School of Medicine
Key Advantages of nanogel Delivery
The research highlights several key benefits of using nanogel technology for antibiotic delivery:
- Increased Gentamicin Delivery: nanogels can carry approximately 36% more gentamicin inside cells compared to standard methods.
- Low Toxicity: The nanogels exhibit minimal harm to cells, ensuring a safer treatment option.
- Rapid Drug Release: Nanogels release the drug quickly,accelerating the process of bacterial elimination in the bladder.
Precision Targeting for Reduced Side Effects
The targeted approach of nanogel delivery aims to minimize side effects and reduce the risk of antibiotic resistance.
We believe this new approach offers a more effective treatment by delivering the drug directly to the infected cells, allowing it to precisely target and eliminate the infection.This method minimizes side effects and reduces the risk of antibiotic resistance. In contrast, current antibiotics may require prolonged or repeated therapy to be effective, which can contribute to resistance and cause harmful side effects, especially in organs like the kidneys.
Devatha Nair, PhD, associate professor in craniofacial biology at the University of Colorado School of Dental Medicine
Potential Applications Beyond UTIs
Researchers suggest that this nanogel-based drug delivery method could extend beyond UTIs. The CU School of Dental Medicine initially conceived the idea for treating periodontal disease.
Collaborative Research Effort
The study involved experts from various schools and colleges within the CU Anschutz Medical Campus. The nanogels were developed in Nair’s polymer lab, while the peptide was studied in dmitri simberg’s, PhD, lab at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.
Humberto Escobedo, PhD, played a crucial role in developing the targeted drug delivery system, integrating polymer chemistry, pharmacology, microbiology, and urogynecology.
Marsha K.Guess, MD, MS, and her team collaborated with Schurr’s lab to develop and test the approach, focusing on its translational potential for human use.
This is an exciting advancement for the delivery of medicine and the potential to improve the quality of life for many people. For urinary tract infections, they are not only common and costly but also debilitating, severely affecting the quality of life for those who suffer from them. Advancing research to develop more effective, long-lasting treatments is a crucial step in enhancing overall health and well-being.
Michael Schurr, PhD
Funding
This research was supported by funding from the National Institutes of Health (NIH).
Nanogel Drug Delivery for UTIs: Q&A on this Promising New Treatment
Urinary tract infections (UTIs) are a common ailment, especially among women, and can considerably impact quality of life. Recurrent UTIs present an even greater challenge. Researchers are exploring innovative solutions,and a recent study highlights teh potential of nanogel-based drug delivery systems.Here’s everything you need to know:
What are Nanogels and How Do They Work in Treating UTIs?
Nanogels are tiny, gel-like particles used to deliver drugs directly to specific areas in the body. In the context of UTIs,researchers at the University of Colorado Anschutz Medical Campus are using nanogels to deliver the antibiotic gentamicin directly into the bladder tissue. These nanogels are combined wiht a special peptide that helps the drug penetrate the cells where bacteria frequently enough hide, making the treatment more effective.
How Effective is nanogel Delivery for UTIs?
In animal models, the nanogel treatment proved highly effective, eliminating over 90% of the bacteria from the bladder. Michael Schurr,PhD,an associate professor at the University of Colorado School of Medicine,stated that this research demonstrates that this technology is not only feasible but could also be very effective for future clinical use.
What are the Key Benefits of Using nanogel Technology Compared to Traditional Antibiotics?
Nanogel technology offers several advantages over traditional antibiotic treatments for UTIs:
Increased Drug Delivery: Nanogels can carry approximately 36% more gentamicin inside cells than standard methods.
Low Toxicity: The nanogels exhibit minimal harm to cells, making them a safer treatment option.
Rapid Drug Release: nanogels release the drug quickly, accelerating the process of bacterial elimination in the bladder.
Precision Targeting: Nanogel delivery aims to minimize side effects and reduce the risk of antibiotic resistance by delivering the drug directly to the infected cells.
How Does Nanogel Delivery Reduce the Risk of Antibiotic Resistance?
traditional antibiotics often require prolonged or repeated therapy to be effective, which can contribute to antibiotic resistance and cause harmful side effects. The nanogel approach delivers the drug directly to the infected cells,allowing it to precisely target and eliminate the infection. This targeted approach reduces the need for high doses of antibiotics and minimizes exposure to non-infected areas, thereby reducing the risk of resistance.
What is Gentamicin?
Gentamicin is an aminoglycoside antibiotic used to treat various bacterial infections. It effectively works by inhibiting protein synthesis in bacteria, leading to their death.
Could this Nanogel Technology be Used for Other Infections?
Yes,researchers believe that this nanogel-based drug delivery method has potential applications beyond UTIs.The CU School of Dental Medicine initially conceived the idea for treating periodontal disease. Nanogels are being explored as drug-delivery systems with site-specific or time-controlled release of bioactive mediators, indicating a broad range of potential applications.
Who is Involved in This Nanogel Research?
This research is a collaborative effort involving experts from various schools and colleges within the CU Anschutz Medical Campus, including:
Devatha Nair, PhD: Associate professor in craniofacial biology, whose polymer lab developed the nanogels.
Dmitri Simberg, PhD: From the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, whose lab studied the peptide used in conjunction with the nanogels.
Humberto Escobedo, phd: Played a crucial role in developing the targeted drug delivery system.
Marsha K. Guess, MD, MS: Collaborated with Schurr’s lab to develop and test the approach for human use.
* Michael Schurr, phd: Associate professor in the department of Immunology & Microbiology.
Who Funded the Nanogel research?
This research was supported by funding from the National Institutes of Health (NIH).
Nanogel Delivery vs. Traditional antibiotics: A Comparison
| Feature | Nanogel Delivery | Traditional Antibiotics |
|———————–|———————————————————————————–|————————————————————————————————————————-|
| Drug Delivery | Targeted delivery directly to infected cells | Systemic distribution throughout the body |
| Gentamicin Delivery Inside Cells | 36% higher than standard methods | Varies, typically lower intracellular concentration |
| Toxicity | Low toxicity, minimal harm to cells | Potential for kidney and other organ damage with prolonged or repeated use |
| Risk of Resistance | Lower risk due to targeted approach and reduced exposure in the body | Higher risk due to widespread exposure and potential for bacteria to develop resistance mechanisms |
| Side Effects | Minimized due to precision targeting | More likely, especially with prolonged use |
| speed of Action | Rapid drug release and bacterial elimination | Varies depending on the antibiotic and the severity of the infection |